来自中国科学技术大学的最新研究为肝细胞癌（HCC）复发风险评估开辟了新纪元。孙成教授研究组与合作者们成功开发了一款基于空间免疫特征的预测平台，标志着肿瘤空间免疫学领域的重要里程碑。这一研究成果以"Spatial Immune Scoring System Predicts Hepatocellular Carcinoma Recurrence"为题，于2025年3月13日在《自然》期刊正式发表。

The scoring method, called the Tumor Immune Microenvironment Spatial System, or TIMES, is the first tool in the world to ...

A research team led by Prof. SUN Cheng from the University of Science and Technology of China (USTC) of the Chinese Academy of Sciences, along with collaborators from the Agency for Science, ...

Chinese scientists and their Singaporean collaborators have developed a scoring system to predict the risk of recurrence for ...

Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Liver cancer is the fourth most common cancer and the fourth leading cause of cancer-related deaths in the country.

Affected populations: PFIC is a group of rare genetic diseases that cause progressive liver failure. The exact prevalence of ...

One of the world's most globally recognised liver cancer treatments will receive public funding from today. Tecentriq ...